×
<- Back

First use of Creatine Hydrochloride in Premanifest Huntington Disease

  • : Online

Description

 

Huntington disease is a devastating autosomal dominant neurodegenerative disorder that typically manifests between ages 30 and 50 years. Promising high-dose creatine monophosphate trials have been limited by patient tolerance.

This is the first report of use of creatine hydrochloride in two premanifest Huntington disease patients, with excellent tolerability over more than 2 years of use.

 

 

Learning Outcomes

 

  • Understand of treatment outcomes with creatine hydrochloride in two premanifest Huntington disease patients
Delivery
Title
First use of Creatine Hydrochloride in Premanifest Huntington Disease
Location
Duration
30 minutes
CPD
30 minutes
Price
0.00
Location
Online
Contact Phone
Log in into view this field.
4 Views
Similar Courses and Events
HealthcareLink